Skip to content

Burden of TB, latent TB and drug resistance among tribal rajasthan.

Estimate the burden of TB (Active and Latent) among the tribal population and their anti-TB drug resistance pattern to strengthen TB control in the tribal areas. - Nill

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/09/058016
Enrollment
5500
Registered
2023-09-26
Start date
Unknown
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Department of Science and Technology 1819 scheme
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participants who will give their informed consent from

Exclusion criteria

Exclusion criteria: Age

Design outcomes

Primary

MeasureTime frame
The findings of the study would provide valuable information on TB disease prevalence amongst the tribal groups (TGs) in the country along with the extent of MDR TB. The findings of the study would provide valuable information on Latent TB disease prevalence amongst the high-risk tribal groups (TGs) Timepoint: The detailed break up is as follows Phase I – 5 months Phase II – 5 months (including transcribing data) Phase III – 20 months (Including data entries) Final Analysis of Data – 6 months

Secondary

MeasureTime frame
The study would also throw light on the health seeking behavior of chest symptomatic especially in light of the ongoing RNTCP in these areas In addition the study would identify gaps in programme implementation useful for making necessary modifications in the TB control strategies in the area The study would also determine to an extent the problem of co-infection of HIV-TB & Malnutrition among the chest symptomatic identified during the survey This would help all the three national programmes in tacking these problems in difficult tribal areas The prevalence figures for different Tribal Groups estimated from this study could also serve as a baseline for monitoring changes in prevalence on subsequent follow-up surveys using same methodology in future at regular intervals Insights from descriptive & analytic framework to create a behaviour change model based on qualitative data findingsTimepoint: The detailed break up is as follows Phase I – 5 months Phase II – 5 months (including transcribing data) Phase III – 20 months (Including data entries) Final Analysis of Data – 6 months

Countries

India

Contacts

Public ContactDr shoban babu varthya

AIIMS JODHPUR

drshobanpgimer@gmail.com8437726777

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026